Clinical evaluation of tumor characteristics predisposing serum thyroglobulin to be undetectable in patients with differentiated thyroid cancer

This publication has 19 references indexed in Scilit:

• How to deal with undetectable and low measurable serum thyroglobulin levels in the follow-up of patients with differentiated thyroid carcinoma?
  Acta Endocrinologica, 1985
• Thyroglobulin may be undetectable in the serum of patients with metastatic disease secondary to differentiated thyroid carcinoma. Follow-up of differentiated thyroid carcinoma
  Cancer, 1984
• Long-term follow-up using serial serum thyroglobulin determinations in patients with differentiated thyroid carcinoma
  Cancer, 1983
• A Comparison of Serum Thyroglobulin Measurements and Whole Body 131l Scanning in the Management of Treated Differentiated Thyroid Carcinoma
  Australian and New Zealand Journal of Medicine, 1982
• Sequential Serum Thyroglobulin Determinations,¹³¹I Scans, and¹³¹I Uptakes After Triiodothyronine Withdrawal in Patients with Thyroid Cancer*
  Journal of Clinical Endocrinology & Metabolism, 1981
• The comparative value of serum thyroglobulin measurements and iodine 131 total body scans in the follow-up study of patients with treated differentiated thyroid cancer
  The American Journal of Medicine, 1981
• Thyroglobulin assay in the follow-up of patients with differentiated thyroid carcinomas: comparison of its value in patients with or without normal residual tissue
  Acta Endocrinologica, 1981
• Thyroglobulin and Thyroid Hormone Release after Intravenous Administration of Bovine Thyrotropin in Man*
  Journal of Clinical Endocrinology & Metabolism, 1980
• Serum thyroglobulin in thyroid carcinoma and other thyroid disorders
  Journal of Endocrinological Investigation, 1980
• Elevated serum thyroglobulin. A marker of metastases in differentiated thyroid carcinomas.
  Journal of Clinical Investigation, 1975